课题基金 / 基金详情

GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID

GLYCOPROTEINS EXPRESSING GLYCANS THAT REACT WITH DBA AND ANTI-POLY SIALIC ACID
表达与 DBA 和抗聚唾液酸反应的聚糖的糖蛋白
批准号:
7955995
负责人:
J. Michael Pierce
金额:
$12.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2010-05-31

项目摘要

项目成果

J. Michael Pierce的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Stem Cell Program (Dalton) has identified Dolichos biflorus agglutinin (DBA) positive epitopes on ES cells that disappear when differentiation to EPL and EBods is induced. Lectin blotting with DBA identified 6-10 glycoproteins expressing glycans recognized by DBA. The glycoproteins expressing these glycans are being identified by excision of gel slices, trypsinization, and MALDI-TOF MS analysis. Moreover, the glycans on these glycoproteins are released, tagged with pyridylamine, and identified by chromatographic separation and MALDI-TOF MS. Initial results suggest that the DBA epitopes are on N-linked glycans because of their sensitivity to N-glycans release. Ultimately, we will answer the question of how the DBA glycan reactivity disappears after differentiation. The Glycotranscriptome Program (Moremen) has identified polysialic acid synthase expression in differentiated (EBod) cells. Staining of EBod and not ES cells with antibody specific to polysialic acid confirms this result. We will identify the glycoproteins that express this glycan and their function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)
  • 批准号:
    8708156
  • 项目类别:
  • 资助金额:
    $170.41万
  • 财政年份:
    2014
  • 负责人:
    J. Michael Pierce
  • 依托单位:
Glycoscience Training Program
  • 批准号:
    8742843
  • 项目类别:
  • 资助金额:
    $13.54万
  • 财政年份:
    2014
  • 负责人:
    J. Michael Pierce
  • 依托单位:
Glycoscience Training Program
  • 批准号:
    9104175
  • 项目类别:
  • 资助金额:
    $18.44万
  • 财政年份:
    2014
  • 负责人:
    J. Michael Pierce
  • 依托单位:
TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)
  • 批准号:
    8529766
  • 项目类别:
  • 资助金额:
    $285.93万
  • 财政年份:
    2013
  • 负责人:
    J. Michael Pierce
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: